Cormorant Asset Management, LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $1.72 Million - $2.48 Million	-130,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $2.17 Million - $3.12 Million	130,000 New	130,000 $2.41 Million
Q2 2019 Aug 14, 2019	SELL	$13.2 - $20.39 $3.56 Million - $5.51 Million	-270,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$15.93 - $26.59 $8.94 Million - $14.9 Million	-561,000 Reduced 67.51%	270,000 $4.88 Million
Q2 2018 Aug 14, 2018	BUY	$16.73 - $20.35 $13.9 Million - $16.9 Million	831,000 New	831,000 $13.8 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $677M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.